Myeloablative vs reduced intensity T-cell–replete haploidentical transplantation for hematologic malignancy

In the absence of prospective studies that examine the effect of conditioning regimen intensity after T-cell–replete haploidentical transplant for acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), and myelodysplastic syndrome (MDS), a retrospective cohort analysis was performed. Of t...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Blood Adv
Autors principals: Solomon, Scott R., St. Martin, Andrew, Shah, Nirav N., Fatobene, Giancarlo, Al Malki, Monzr M., Ballen, Karen K., Bashey, Asad, Bejanyan, Nelli, Bolaños Meade, Javier, Brunstein, Claudio G., DeFilipp, Zachariah, Champlin, Richard E., Fuchs, Ephraim J., Hamadani, Mehdi, Hematti, Peiman, Kanakry, Christopher G., McGuirk, Joseph P., McNiece, Ian K., Ciurea, Stefan O., Pasquini, Marcelo C., Rocha, Vanderson, Romee, Rizwan, Patel, Sagar S., Vasu, Sumithira, Waller, Edmund K., Wingard, John R., Zhang, Mei-Jie, Eapen, Mary
Format: Artigo
Idioma:Inglês
Publicat: American Society of Hematology 2019
Matèries:
Transplantation
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6784523/
https://ncbi.nlm.nih.gov/pubmed/31582392
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2019000627
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars